Monopar Therapeutics Statistics
NASDAQ: MNPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
69.00-1.29 (-1.84%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Monopar Therapeutics by the numbers
Monopar Therapeutics has a market capitalization of $467.6 million based on 6.78M shares outstanding. With trailing EPS of $-2.44, Monopar Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.9% below its 50-day average and 11.0% below its 200-day average.
Average daily trading volume is 151.83K shares, or about $10.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MNPR valuation vs. peer median
| Metric | MNPR | Peer median | Difference |
|---|---|---|---|
| Market cap | $467.60M | $461.00M | +1% |
| Avg. volume | 151.83K | 308.58K | -51% |
Peer median across 8 companies: EVO, RZLT, HELP, BLSM, GYRE, NGNE, ASMB, STTK.
Valuation
- Market cap
- $467.60M
- EPS (TTM)
- $-2.44
- Shares outstanding
- 6.78M
Price and trading
- Previous close
- 70.29
- Open
- 68.50
- Day range
- 67.36 – 69.86
- 52-week range
- 50.07 – 124.82
- 52-week change
- -24.64%
- Beta
- —
- Volume
- 132.61K
- Average volume
- 151.83K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 467.60M
- Forward Pe
- -20.39
- Eps
- -2.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 124.82
- Week52 Low
- 50.07
- Avg Volume
- 151.83K
- Shares Outstanding
- 6.78M
- Ma50
- 78.36
- Ma200
- 77.49
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -44.72%
- Pct From52w Low
- 37.81%